John Couling - Nov 15, 2023 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
SVP, Entertainment
Signature
/s/ Daniel Rodriguez, Attorney-in-Fact for John Couling
Stock symbol
DLB
Transactions as of
Nov 15, 2023
Transactions value $
-$6,998
Form type
4
Date filed
11/17/2023, 04:10 PM
Previous filing
May 16, 2023
Next filing
Dec 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Sale -$7K -79 -0.08% $88.58 96.4K Nov 15, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held following the reported transaction include 43,636 restricted stock units, which are subject to forfeiture until they vest.
F2 Shares include (1) 87 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2021, (2) 38 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2022, and (3) 79 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2023. The shares acquired on November 15, 2021 and November 15, 2022 were not included in share totals reported previously due to administrative error.

Remarks:

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 17, 2022, as amended February 6, 2023, which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.